Check Cap LtdNASDAQ:CHEK
- LAST PRICE0.8230
- TODAY'S CHANGE (%)0.0129 (1.5924%)
- Bid / Lots0.7822/ 30
- Ask / Lots0.8300/ 1
- Open / Previous Close0.8144 / 0.8101
- Day Range
- 52 Week Range
- Volume7,147
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CHEK |
|---|---|---|
| 09:32 ET | 463 | 0.8144 |
| 09:35 ET | 804 | 0.855 |
| 09:46 ET | 150 | 0.82 |
| 10:22 ET | 377 | 0.8252 |
| 11:23 ET | 100 | 0.819 |
| 11:38 ET | 177 | 0.823 |
| 11:43 ET | 152 | 0.7841 |
| 12:33 ET | 126 | 0.82 |
| 12:37 ET | 100 | 0.7804 |
| 12:46 ET | 110 | 0.80005 |
| 02:38 ET | 356 | 0.81 |
| 02:43 ET | 100 | 0.823 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Check Cap Ltd | 4.7M | -0.3x | --- |
Portage Biotech Inc | 4.7M | -0.1x | --- |
Bionomics Ltd | 4.8M | 0.0x | --- |
Purple Biotech Ltd | 4.8M | 0.0x | --- |
Nymox Pharmaceutical Corp | 4.7M | -0.5x | --- |
Hepion Pharmaceuticals Inc | 4.8M | -0.1x | --- |
Company Information
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Contact Information
- Headquarters
- 29 Abba Hushi Ave., Isfiya P.O.Box 1271, Israel 3009000
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Steven Hanley
- Chief Executive Officer
- Alex Ovadia
- Chief Financial Officer
- Dan Hilerowitz
- Chief Technology Officer
- Yoav Kimchy
- Vice President - Operations
- Joshua Belkar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 5.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.16 |
EPS | $-3.00 |
Book Value | $4.05 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
